Manood ng libreng bidyo CureVac - Ingmar Hoerr, CEO

(38.8 MB) idinagdag ng 29 Mar 2017 108 beses na nalaro Negosyo Social Technology Finance
I-reset
Zoom out
Zoom in
CureVac - Ingmar Hoerr, CEO

flowplayer
00:00 00:00

spaceplay / pause

qunload | stop

ffullscreen

shift + ←→slower / faster

↑↓volume

mmute

←→seek

 . seek to previous

12… 6 seek to 10%, 20% … 60%

Paglalarawan ng animasyon:

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.